<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04553744</url>
  </required_header>
  <id_info>
    <org_study_id>2020-0099</org_study_id>
    <secondary_id>NCI-2020-06478</secondary_id>
    <secondary_id>2020-0099</secondary_id>
    <nct_id>NCT04553744</nct_id>
  </id_info>
  <brief_title>Identification of Surgical Management of Lymph Node Basins and Surgical Practice Patterns Among Sarcoma Surgeons</brief_title>
  <official_title>Survey of Extremity and Trunk Sarcoma Surgeons Regarding Surgical Management of Lymph Node Basins</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>M.D. Anderson Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>M.D. Anderson Cancer Center</source>
  <brief_summary>
    <textblock>
      This study investigates the surgical management of lymph node basins for extremity and trunk&#xD;
      soft tissue sarcoma (ETSTS) to identify and better understand the surgical practice patterns&#xD;
      of sarcoma surgeons. ETSTS has been known to spread to distant locations including lymph&#xD;
      nodes, with some subtypes of the disease spreading to lymph nodes more than others. This has&#xD;
      led to sarcoma surgeons to treat patients differently from one another, including those with&#xD;
      more lymph node involvement. The purpose of this study is to investigate the practice&#xD;
      patterns of ETSTS surgeons.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVES:&#xD;
&#xD;
      I. Identify the practice patterns of sarcoma surgeons with respect to management of lymph&#xD;
      node basins for extremity and trunk soft tissue sarcomas (ETSTS).&#xD;
&#xD;
      II. Identify when surgeons would perform sentinel lymph node biopsy and/or lymph node&#xD;
      dissection for ETSTS and if management differs for high-risk subtypes of sarcoma that are&#xD;
      more likely to have nodal metastases.&#xD;
&#xD;
      III. Identify differences in practice patterns between surgical oncologists and orthopedic&#xD;
      oncologic surgeons.&#xD;
&#xD;
      OUTLINE:&#xD;
&#xD;
      Participants complete an online survey over 5-10 minutes asking how they would manage lymph&#xD;
      node basins in the extremity sarcoma.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 22, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Practice patterns of sarcoma surgeons</measure>
    <time_frame>Up to 2 years</time_frame>
    <description>Will identify the practice patterns of sarcoma surgeons with respect to management of lymph node basins for extremity and trunk soft tissue sarcomas (ETSTS).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sentinel lymph node biopsy and/or lymph node dissection for ETSTS</measure>
    <time_frame>Up to 2 years</time_frame>
    <description>Will identify when surgeons would perform sentinel lymph node biopsy and/or lymph node dissection for ETSTS, and if management differs for high-risk subtypes of sarcoma that are more likely to have nodal metastases.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Differences in practice patterns</measure>
    <time_frame>Up to 2 years</time_frame>
    <description>Will identify differences in practice patterns between surgical oncologists and orthopedic oncologic surgeons.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Soft Tissue Sarcoma of the Trunk and Extremities</condition>
  <arm_group>
    <arm_group_label>Observational (survey)</arm_group_label>
    <description>Participants complete an online survey over 5-10 minutes asking how they would manage lymph node basins in the extremity sarcoma.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Survey Administration</intervention_name>
    <description>Complete survey</description>
    <arm_group_label>Observational (survey)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Practicing surgeons who are members of The Society of Surgical Oncology and Musculoskeletal&#xD;
        Tumor Society, and treat extremity and trunk soft tissue sarcomas.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Currently practicing surgeons who treat ETSTS and are members of The Society of&#xD;
             Surgical Oncology and Musculoskeletal Tumor Society&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christina L Roland</last_name>
    <role>Principal Investigator</role>
    <affiliation>M.D. Anderson Cancer Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christina L Roland</last_name>
    <phone>713-792-6940</phone>
    <email>clroland@mdanderson.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>M D Anderson Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christina L. Roland</last_name>
      <phone>713-792-6940</phone>
      <email>clroland@mdanderson.org</email>
    </contact>
    <investigator>
      <last_name>Christina L. Roland</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.mdanderson.org</url>
    <description>MD Anderson Cancer Center Website</description>
  </link>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 11, 2020</study_first_submitted>
  <study_first_submitted_qc>September 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 17, 2020</study_first_posted>
  <last_update_submitted>September 11, 2020</last_update_submitted>
  <last_update_submitted_qc>September 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sarcoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

